focus -WSS

focus

author：entertainment 2025-09-03 05:25:44 - browse：34

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout Newsletter: Merck, J&J, and long Covid

entertainment

WSS

Time to name cancers by genetics, not organ of origin, expert says

Francis Collins on trust in science and how Covid communications failed

Why doctors need education on FDA device approval process

Why doctors need education on FDA device approval process

Medicare Advantage today, explained in one chart

Commercial surrogacy can be ethical, despite pope’s claims

knowledge

focus

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why doctors need education on FDA device approval process

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Quicker fix for pulse oximeters urged during FDA public meeting

Trump demands the U.S. pay no more for drugs than other countries … again

Even great ERs can’t make up for American health disparities

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Vertex non

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

Why doctors need education on FDA device approval process

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Cognito secures funding to test medical device for Alzheimer's

Francis Collins on trust in science and how Covid communications failed

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

NIH director takes cautious approach to Biden drug pricing priority

Wikipedia

entertainment

entertainment

knowledge